Effects of morning versus evening dose of hydroxyzine 50 mg on cognition in healthy subjects

Phase 4

Completed

• Conditions: cognitief functioneren; sedation / drowsiness

• Registration Number: NL-OMON33183
• Lead Sponsor: niversiteit Maastricht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 22

Inclusion Criteria

1. Healthy
2. Between 18 and 45 years of age
3. BMI between 19 and 30
4. Able to give a written informed consent and to understand the protocol

Exclusion Criteria

1. Pregnancy
2. Use of antihistamine
3. Excessive alcohol, nicotine and/or caffeine consumption
4. Psychiatric illness

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The Mean Absolute Tracking Error (mm) in the Divided Attention Task </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Cognitieve tests: Attentional Network Test; Critical Tracking Test; Divided<br /><br>attention Test; Stop Signal Test; Attentional Switch Test; Event related<br /><br>potentials: P1/N1, N2, P3.<br /><br>Subjectieve evaluaties: Groningen Sleepiness Questionnaire; Subjective<br /><br>Alertness Bond en Lader Visual Analogue Scale</p><br>